Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180‐week follow‐up results from the ph...

por Yamanaka, Keiichi, Okubo, Yukari, Yasuda, Ikuko, Saito, Nobuo, Messina, Izabella, Morita, Akimichi
Publicado 2022

Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

por Tyring, Stephen K., Rich, Phoebe, Tada, Yayoi, Beeck, Stefan, Messina, Izabella, Liu, Jie, Huang, Xiaohong, Shumack, Stephen
Publicado 2023

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

por Kimball, Alexa B., Prens, Errol P., Passeron, Thierry, Maverakis, Emanual, Turchin, Irina, Beeck, Stefan, Drogaris, Leonidas, Geng, Ziqian, Zhan, Tianyu, Messina, Izabella, Bechara, Falk G.
Publicado 2023